Search Results - "Kaiser, Andreas F. C."

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy by Neubauer, Horst, Kaiser, Andreas F C, Endres, Heinz G, Krüger, Jan C, Engelhardt, Andreas, Lask, Sebastian, Pepinghege, Fenena, Kusber, Andreas, Mügge, Andreas

“…Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable…”
Get full text

Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD by Meves, Saskia H., Hummel, Thomas, Endres, Heinz G., Mayböck, Nora, Kaiser, Andreas F. C., Schröder, Kay D., Rüdiger, Katja, Overbeck, Ursula, Mumme, Achim, Mügge, Andreas, Neubauer, Horst

“…Although acetylsalicylic acid (ASA, aspirin) reduces the risk of ischemic events in patients with atherosclerosis, a substantial number of incidents continue…”
Get full text

Cytochrome P450 2B6 and 2C9 genotype polymorphism--a possible cause of prasugrel low responsiveness by Franken, Cora C, Kaiser, Andreas F C, Krüger, Jan C, Overbeck, Kristina, Mügge, Andreas, Neubauer, Horst

“…The cytochrome P450 (CYP) isoenzymes are essential for the metabolic activation of the prodrug prasugrel. Little is known about the impact of polymorphism of…”
Get more information

BAPA, a synthetic dual inhibitor of Factor Xa and Thrombin, extends the storage-time to a maximum of 12 hours in ADP- and 24 hours in arachidonic acid-induced impedance aggregometry by Kaiser, Andreas F. C., Endres, Heinz G., Mügge, Andreas, Neubauer, Horst

“…Abstract Impedance aggregometry is mainly limited by the time-dependent instability of platelets in whole blood samples, caused by the influence of ex-vivo…”
Get full text